2 ms·
These days big pharma has outsourced all their early stage development to startups, purchasing compounds in the late stages through acquisition. They do pay for
by epistasis 15y ago
These days big pharma has outsourced all their early stage development to startups, purchasing compounds in the late stages through acquisition. They do pay for research, but it's not going to look that way on their balance sheet.
Their primary function, as you say, is shifting far towards the marketing end.